Premium
Are there new threshold and goals in the treatment of arterial hypertension?
Author(s) -
Segura Julian,
Ruilope Luis M.
Publication year - 2012
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/j.1365-2362.2012.02658.x
Subject(s) - medicine , blood pressure , disease , cardiology , diabetes mellitus , intensive care medicine , prospective cohort study , endocrinology
Eur J Clin Invest 2012 Abstract Background About half of the global burden of cardiovascular disease has been attributed to high blood pressure (BP). Worldwide, 7·6 million premature deaths (about 13·5% of the global total), 54% of strokes, and 47% of cases of ischemic heart disease were caused by high BP in 2001. Methods and results All guidelines agree that pharmacological treatment of patients with hypertension should be initiated as soon as BP rises >140/90 mmHg. Available data support the reduction of BP to values to <140/90 mmHg, but do not favor a reduction to <130/80 mmHg in patients with diabetes or a history of cardiovascular disease because of the absence of evidence obtained in prospective studies. Conclusions This review updates the controversies and challenges involved in the treatment of patients with established arterial hypertension, such as the progression of high‐normal BP to overt hypertension, the choice of appropriate threshold and goal BP levels, the adequate number of drugs to be used since the early stages of hypertension, and which type of combination therapy offers most advantages to the patient.